Showing results (771-780 of 1,218) with videos related to

Sort By:
Pageof 122
The Plant Cell|October 17, 2019
Depletion of the FtsH1/3 Proteolytic Complex Suppresses the Nutrient Stress Response in the Cyanobacterium Synechocystis sp strain PCC 6803Vendula Krynická, Jens Georg, Philip J Jackson, et al.
Peptide Research|May 1, 1994
Covalent immunochemical membrane labeling of viable cells with K698-T708, a simian virus 40 tumor antigen-derived peptideR Hess, P Rau, M Schwab, et al.
The Journal of Biological Chemistry|March 27, 2020
RNA helicase-regulated processing of the Synechocystis rimO-crhR operon results in differential cistron expression and accumulation of two sRNAsAlbert Remus R Rosana, Denise S Whitford, Anzhela Migur, et al.
Respiratory Care|December 28, 2017
Clinical Effectiveness of Incentive Spirometry for the Prevention of Postoperative Pulmonary ComplicationsAdam E M Eltorai, Ashley L Szabo, Valentin Antoci, et al.
Transfusion|October 22, 2025
Rapid oxygen release from stored red blood cells can be preserved for longer with refined additive solutionsJulija Rabcuka, Athinoula Meli, Jennifer Jolley, et al.
Journal of Neuro-Oncology|December 6, 2017
Volumetric response of progressing post-SRS lesions treated with laser interstitial thermal therapyVivek B Beechar, Sujit S Prabhu, Dhiego Bastos, et al.
Anesthesia and Analgesia|May 6, 2022
Platelet Transfusion and Outcomes After Massive Transfusion Protocol Activation for Major Trauma: A Retrospective Cohort StudyPudkrong K Aichholz, Sarah A Lee, Carly K Farr, et al.
The Annals of Thoracic Surgery|October 10, 2020
The Impact of Race on Outcomes of Revascularization for Multivessel Coronary Artery DiseaseNicholas R Hess, Laura Seese, Ibrahim Sultan, et al.
The Journal of Pathology|April 30, 2016
Glioma progression is mediated by an addiction to aberrant IGFBP2 expression and can be blocked using anti-IGFBP2 strategiesLynette M Phillips, Xinhui Zhou, David E Cogdell, et al.
International Journal of Cancer|September 8, 2016
Outcomes of patients ≥65 years old with advanced cancer treated on phase I trials at MD ANDERSON CANCER CENTERIshwaria M Subbiah, Jennifer J Wheler, Kenneth R Hess, et al.
Pageof 122